STRATA Skin Sciences, Inc. (SSKN) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21
	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q
Revenues, net	8.3	7.6	10.6	9.4	9.1	7.0	9.1	7.7
Revenues, net growth	-9.4%	7.5%	17.1%	22.1%	23.3%	20.8%	34.8%	37.4%
Cost of revenues	3.9	3.2	3.8	3.6	4.1	2.9	3.1	2.3
Gross profit	4.3	4.4	6.8	5.8	5.0	4.1	6.0	5.4
Gross margin	52.3%	58.0%	64.6%	61.6%	54.8%	58.6%	66.2%	69.7%

Operating expenses:
Engineering and product development	0.4	0.3	0.4	0.2	0.2	0.2	0.3	0.4
Selling and marketing	3.4	3.7	3.8	3.8	4.1	3.6	3.7	3.3
General and administrative	2.5	2.9	2.5	2.6	2.3	2.7	2.6	2.2
Total operating expenses	16.5	17.1	17.2	16.8	17.5	15.8	16.3	14.0
Loss from operations	-2.0	-2.6	0.1	-0.8	-1.7	-2.3	-0.6	-0.5
Operating margin	-23.8%	-34.2%	1.3%	-8.4%	-18.6%	-32.7%	-6.9%	-6.0%

Other (expense) income:
Loss on debt extinguishment	-0.9
Interest expense	-0.3	-0.3	-0.3	-0.2	-0.2	-0.2	-0.2	-0.1
Interest income	0.0	0.0	0.0	0.0	0.0		0.0	0.0
Other (expense), income net	-1.2	-0.2	-0.2	-0.2	-0.2	-0.2	-0.2	-0.1
Net loss	-3.1	-2.8	-0.2	-1.0	-1.9	-2.5	-0.8	-0.5

Net loss per share of common stock - basic (in dollars per share)	($0.09)	($0.08)		($0.03)	($0.05)	($0.07)	($0.03)	($0.02)
Net loss per share of common stock - diluted (in dollars per share)	($0.09)	($0.08)		($0.03)	($0.05)	($0.07)	($0.03)	($0.02)

Weighted average shares of common stock outstanding - basic (in shares)	34.9	34.9	34.7	34.7	34.7	34.7	34.1	34.2
Weighted average shares of common stock outstanding - diluted (in shares)	34.9	34.9	34.7	34.7	34.7	34.7	34.1	34.2